Hedge Fund and Insider Trading News: Anthony Scaramucci, Solus Alternative Asset Management, Adaptimmune Therapeutics PLC (ADAP), Motorola Solutions Inc (MSI), BK Technologies Inc (BKTI), and More

Ex-White House Staffer Anthony Scaramucci is Selling His $4 Million Hamptons Mansion – Take a Look Inside (CNBC)
Anthony Scaramucci, founder of hedge fund SkyBridge Capital and the Trump administration’s White House communications director for 10 days in 2017, is selling his Southampton, New York beach house for $3.99 million. Scaramucci and wife Diedre Ball bought a larger home in Water Mill that was asking $7.49 million, according to Realtor.com. Take a look inside the $3.99 million Southampton home. The four-bedroom, 4.5-bathroom Southampton house sits on a third of an acre, and it was recently renovated and expanded to 4,000 square feet.

We Didn’t Kill Toys ‘R’ Us, Solus Tells Investors (Bloomberg)
Solus Alternative Asset Management LP didn’t kill Toys “R” Us Inc., the hedge fund said in a letter to its investors after coming under pressure for its investments in the liquidating retailer. “Solus did not force Toys ‘R’ Us to liquidate,” Chief Investment Officer Christopher Pucillo said in the Sept. 6 letter seen by Bloomberg News. “It was the culmination of a host of factors, including a decade-plus of excessive leverage, mismanagement and the increasing effects of competition from the likes of Amazon and Walmart.”

Countries with the Smallest Government Per Capita in the World

Pressmaster/Shutterstock.com

Insider Selling: Motorola Solutions Inc (MSI) Chairman Sells 204,953 Shares of Stock (WeekHerald)
Motorola Solutions Inc (NYSE:MSI) Chairman Gregory Q. Brown sold 204,953 shares of the stock in a transaction on Friday, September 14th. The stock was sold at an average price of $126.47, for a total value of $25,920,405.91. The transaction was disclosed in a document filed with the SEC.

Insider Buying: Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) Director Buys 12,000,000 Shares of Stock (XNewsPress.com)
Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) Director Ali Behbahani acquired 12,000,000 shares of the business’s stock in a transaction that occurred on Friday, September 7th. The stock was bought at an average cost of $1.67 per share, for a total transaction of $20,040,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: BK Technologies Inc (NYSEAMERICAN:BKTI) Director Acquires 692,534 Shares of Stock (MareaInformativa.com)
BK Technologies Inc (NYSEAMERICAN:BKTI) Director Global Investors Fundamental bought 692,534 shares of the business’s stock in a transaction that occurred on Sunday, September 9th. The stock was acquired at an average cost of $3.95 per share, for a total transaction of $2,735,509.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

CBIZ, Inc. (CBZ) Insider Michael W. Gleespen Sells 27,000 Shares (FairFieldCurrent.com)
CBIZ, Inc. (NYSE:CBZ) insider Michael W. Gleespen sold 27,000 shares of CBIZ stock in a transaction on Thursday, August 23rd. The shares were sold at an average price of $23.42, for a total value of $632,340.00. Following the completion of the transaction, the insider now owns 118,880 shares in the company, valued at approximately $2,784,169.60. The sale was disclosed in a document filed with the Securities & Exchange Commission.

Xencor Inc (XNCR) Insider Paul A. Foster Sells 40,000 Shares (MareaInformativa.com)
Xencor Inc (NASDAQ:XNCR) insider Paul A. Foster sold 40,000 shares of the stock in a transaction dated Monday, September 17th. The stock was sold at an average price of $46.03, for a total transaction of $1,841,200.00. Following the transaction, the insider now owns 44,952 shares in the company, valued at $2,069,140.56. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Insider Selling: Nantkwest Inc (NASDAQ:NK) Director Sells $65,713.50 in Stock (XNewsPress.com)
Nantkwest Inc (NASDAQ:NK) Director Steve Gorlin sold 21,475 shares of the stock in a transaction dated Thursday, August 23rd. The shares were sold at an average price of $3.06, for a total value of $65,713.50. Following the completion of the sale, the director now owns 224,805 shares of the company’s stock, valued at approximately $687,903.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission.